Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

814 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Guidelines for the medical treatment of idiopathic pulmonary fibrosis.
Xaubet A, Molina-Molina M, Acosta O, Bollo E, Castillo D, Fernández-Fabrellas E, Rodríguez-Portal JA, Valenzuela C, Ancochea J. Xaubet A, et al. Among authors: valenzuela c. Arch Bronconeumol. 2017 May;53(5):263-269. doi: 10.1016/j.arbres.2016.12.011. Epub 2017 Mar 11. Arch Bronconeumol. 2017. PMID: 28292522 English, Spanish.
Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis.
Flaherty KR, Fell CD, Huggins JT, Nunes H, Sussman R, Valenzuela C, Petzinger U, Stauffer JL, Gilberg F, Bengus M, Wijsenbeek M. Flaherty KR, et al. Among authors: valenzuela c. Eur Respir J. 2018 Aug 2;52(2):1800230. doi: 10.1183/13993003.00230-2018. Print 2018 Aug. Eur Respir J. 2018. PMID: 29946005 Free PMC article. Clinical Trial.
Role of imaging in progressive-fibrosing interstitial lung diseases.
Walsh SLF, Devaraj A, Enghelmayer JI, Kishi K, Silva RS, Patel N, Rossman MD, Valenzuela C, Vancheri C. Walsh SLF, et al. Among authors: valenzuela c. Eur Respir Rev. 2018 Dec 21;27(150):180073. doi: 10.1183/16000617.0073-2018. Print 2018 Dec 31. Eur Respir Rev. 2018. PMID: 30578332 Free PMC article. Review.
Association of Angiotensin Modulators With the Course of Idiopathic Pulmonary Fibrosis.
Kreuter M, Lederer DJ, Molina-Molina M, Noth I, Valenzuela C, Frankenstein L, Weycker D, Atwood M, Kirchgaessler KU, Cottin V. Kreuter M, et al. Among authors: valenzuela c. Chest. 2019 Oct;156(4):706-714. doi: 10.1016/j.chest.2019.04.015. Epub 2019 Apr 29. Chest. 2019. PMID: 31047956 Free article. Clinical Trial.
The Ariane-IPF ERS Clinical Research Collaboration: seeking collaboration through launch of a federation of European registries on idiopathic pulmonary fibrosis.
Cottin V, Annesi-Maesano I, Günther A, Galvin L, Kreuter M, Powell P, Prasse A, Reynolds G, Richeldi L, Spagnolo P, Valenzuela C, Wijsenbeek M, Wuyts WA, Crestani B; Ariane-IPF Clinical Research Collaboration consortium. Cottin V, et al. Among authors: valenzuela c. Eur Respir J. 2019 May 23;53(5):1900539. doi: 10.1183/13993003.00539-2019. Print 2019 May. Eur Respir J. 2019. PMID: 31123022 Free article. No abstract available.
Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study.
Maher TM, Stowasser S, Nishioka Y, White ES, Cottin V, Noth I, Selman M, Rohr KB, Michael A, Ittrich C, Diefenbach C, Jenkins RG; INMARK trial investigators. Maher TM, et al. Lancet Respir Med. 2019 Sep;7(9):771-779. doi: 10.1016/S2213-2600(19)30255-3. Epub 2019 Jul 17. Lancet Respir Med. 2019. PMID: 31326319 Free article. Clinical Trial.
814 results